Advances in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

ABSTRACT: Balloon pulmonary angioplasty (BPA) is an emerging treatment option for patients with chronic thromboembolic pulmonary hypertension (CTEPH) who have inoperable, segmental/subsegmental disease, or residual disease after pulmonary endarterectomy. In the past decade, advances in the techniques for BPA have led to better clinical outcomes with improvements in hemodynamics, pulmonary perfusion, exercise tolerance, functional capacity, and quality of life. We present the experience with BPA at our university, the largest CTEPH center in the world, followed by reviewing the published data regarding the efficacy and safety of BPA in patients with CTEPH. There is increasing evidence to support that the initial hemodynamic improvement is sustained for ≥3 years after the procedure. Although infrequen

SUBMITTER: Mahmud E 

PROVIDER: S-EPMC8150503 | biostudies-literature | 2021 Apr-Jun

REPOSITORIES: biostudies-literature